Top Markets
Coin of the day
Izotropic Corporation Izotropic Corporation

Izotropic Corporation

IZO
Rank in Stocks #31756
Izotropic Corporation operates as a MedTech enterprise, concentrating on the... Izotropic Corporation operates as a MedTech enterprise, concentrating on the commercialization of diagnostic solutions for breast cancer. Their primary focus lies in developing and offering a breast CT imaging system alongside a 3D CT breast imaging platform, both specifically designed to enable earlier detection and more accurate diagnosis of the disease. Established in 2016, the company maintains its corporate base in Surrey, Canada.
Share Price
$0.17614485
Last synced: 2026-08-17
Market Cap
$12.15M
Change (1 day)
-2.04%
Change (1 year)
-13.19%
Country
CA
Trade Izotropic Corporation (IZO)

Category

Revenue for Izotropic Corporation (IZO)
Revenue in Aug 2026 TTM: 0
According to Izotropic Corporation latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Izotropic Corporation from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$46.34B -
US
$25.11B -
US
- -
CN
$2.71B -
US
$4.55B -
US